Company Analysis National Health Investors, Inc.
1. Summary
Advantages
- Dividends (4.95%) are higher than the sector average (3.28%).
- Current debt level 43.84% is below 100% and has decreased over 5 years from 47.7%.
- The company's current efficiency (ROE=10.53%) is higher than the sector average (ROE=1.96%)
Disadvantages
- Price (71.61 $) is higher than fair price (34.16 $)
- The stock's return over the last year (-9.82%) is lower than the sector average (-7.1%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| National Health Investors, Inc. | Real Estate | Index | |
|---|---|---|---|
| 7 days | -1.2% | -8.4% | -0.4% |
| 90 days | 0.2% | -11.3% | 6% |
| 1 year | -9.8% | -7.1% | 9.2% |
NHI vs Sector: National Health Investors, Inc. has slightly underperformed the "Real Estate" sector by -2.72% over the past year.
NHI vs Market: National Health Investors, Inc. has significantly underperformed the market by -19.05% over the past year.
Stable price: NHI is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NHI with weekly volatility of -0.1889% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (71.61 $) is higher than the fair price (34.16 $).
Price is higher than fair: The current price (71.61 $) is 52.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (22.03) is lower than that of the sector as a whole (72.5).
P/E vs Market: The company's P/E (22.03) is lower than that of the market as a whole (61.83).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.19) is higher than that of the sector as a whole (-8.76).
P/BV vs Market: The company's P/BV (2.19) is lower than that of the market as a whole (20.82).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (9.07) is higher than that of the sector as a whole (8.18).
P/S vs Market: The company's P/S indicator (9.07) is lower than that of the market as a whole (16).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (15.77) is lower than that of the sector as a whole (153.35).
EV/Ebitda vs Market: The company's EV/Ebitda (15.77) is lower than that of the market as a whole (27.04).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -5.09% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.09%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-7.74%).
5.4. ROE
ROE vs Sector: The company's ROE (10.53%) is higher than that of the sector as a whole (1.96%).
ROE vs Market: The company's ROE (10.53%) is lower than that of the market as a whole (43%).
5.5. ROA
ROA vs Sector: The company's ROA (5.41%) is higher than that of the sector as a whole (2.97%).
ROA vs Market: The company's ROA (5.41%) is lower than that of the market as a whole (23.28%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (3.86%) is lower than that of the sector as a whole (6.96%).
ROIC vs Market: The company's ROIC (3.86%) is lower than that of the market as a whole (9.2%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.95% is higher than the average for the sector '3.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.95% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 4.95% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (113.43%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
